SmartKem, Inc. 8-K

What Happened

• On April 21, 2026, SmartKem, Inc. was notified by a Nasdaq Hearings Panel that the company has regained compliance with the stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(2) and has otherwise evidenced compliance with other applicable continued-listing criteria. The company filed the related Form 8-K on April 23, 2026.
• The company remains noncompliant with Nasdaq’s minimum bid-price requirement (Listing Rule 5550(a)(2)) and is subject to a grace period to regain compliance through September 1, 2026.

Key Details

• Notification date: April 21, 2026; Form 8-K filed April 23, 2026.
• Regained compliance: Nasdaq Listing Rule 5550(b)(2) (stockholders’ equity).
• Remaining deficiency: Nasdaq Listing Rule 5550(a)(2) (minimum bid price) — grace period through Sept 1, 2026 to cure.
• Oversight: Subject to a one-year Discretionary Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(A); failure to comply during that year would trigger a delist determination by Nasdaq Listing Qualifications Staff (the company could appeal and request a hearing, which generally stays delisting actions pending the hearing).

Why It Matters

• For investors, the regained equity compliance is a positive regulatory milestone removing one listing deficiency. However, the unresolved bid-price deficiency means delisting risk remains until the company cures the bid-price issue by Sept 1, 2026.
• The one-year Discretionary Panel Monitor increases Nasdaq scrutiny: if SmartKem fails any continued-listing criteria during that period, Nasdaq could move directly to delisting procedures (subject to any appeal/hearing). This oversight and the bid-price issue can affect trading liquidity and investor confidence while unresolved.